As expected, lower SOCS3 and higher pSTAT5 protein levels were observed in BRD9-enriched cells than in control, indicating the BRD9-mediated activation of STAT5 pathway supporting AML tumorigenesis (Fig. 6e and Supplementary Fig. 5b). Here, BRD9 is linked to acute myeloid leukemia.